Is ORPHY or DIVO a better dividend investment in 2026?

ORPHY currently yields 6666.67% with a 5% 5-year dividend growth rate. DIVO yields 6.62% with 5% growth. The better choice depends on your goal: ORPHY offers higher current income.

What is the dividend yield difference between ORPHY and DIVO?

ORPHY has a forward dividend yield of 6666.67% ($2.00/share annually). DIVO yields 6.62% ($2.91/share annually). The yield gap is 6660.05 percentage points.

Home › Compare › ORPHY vs DIVO

ORPHY vs DIVO: Dividend Comparison 2026

ORPHY yields 6666.67% · DIVO yields 6.62%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ORPHY wins by $1028095347812062.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ORPHY

● Live price

6666.67%

Share price

$0.03

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1028095347812062.00M

Annual income

$998,628,545,336,266,700,000.00

Full ORPHY calculator →

DIVO

● Live price

6.62%

Share price

$44.00

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.0K

Annual income

$1,008.47

Full DIVO calculator →

Portfolio growth — ORPHY vs DIVO

📍 ORPHY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ORPHY	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ORPHY + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ORPHY pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ORPHY

Annual income on $10K today (after 15% tax)

$566,666.67/yr

After 10yr DRIP, annual income (after tax)

$848,834,263,535,826,600,000.00/yr

DIVO

Annual income on $10K today (after 15% tax)

$562.67/yr

After 10yr DRIP, annual income (after tax)

$857.20/yr

At 15% tax rate, ORPHY beats the other by $848,834,263,535,826,600,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ORPHY + DIVO for your $10,000?

ORPHY: 50%DIVO: 50%

100% DIVO50/50100% ORPHY

Portfolio after 10yr

$514047673906031.00M

Annual income

$499,314,272,668,133,360,000.00/yr

Blended yield

97.13%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ORPHY buys

DIVO buys

No recent congressional trades found for ORPHY or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricORPHYDIVO

Forward yield	6666.67% ✓	6.62%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$1028095347812062.00M ✓	$31.0K
Annual income after 10y	$998,628,545,336,266,700,000.00 ✓	$1,008.47
Total dividends collected	$1026118102492338.88M ✓	$8.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: ORPHY vs DIVO ($10,000, DRIP)

Year	ORPHY Portfolio	ORPHY Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$677,367	$666,666.67	$11,362	$661.96	+$666.0K → ORPHY
2	$42,928,313	$42,203,530.63	$12,860	$702.91	+$42.92M → ORPHY
3	$2,545,616,701	$2,499,683,405.64	$14,504	$743.56	+$2545.60M → ORPHY
4	$141,255,910,403	$138,532,100,533.89	$16,303	$783.73	+$141255.89M → ORPHY
5	$7,335,374,338,812	$7,184,230,514,680.15	$18,268	$823.31	+$7335374.32M → ORPHY
6	$356,516,885,536,661	$348,668,034,994,132.70	$20,408	$862.17	+$356516885.52M → ORPHY
7	$16,218,956,689,966,618	$15,837,483,622,442,392.00	$22,737	$900.20	+$16218956689.94M → ORPHY
8	$690,711,023,145,868,900	$673,356,739,487,604,600.00	$25,266	$937.31	+$690711023145.84M → ORPHY
9	$27,539,067,734,387,980,000	$26,800,006,939,621,900,000.00	$28,008	$973.42	+$27539067734387.95M → ORPHY
10	$1,028,095,347,812,062,000,000	$998,628,545,336,266,700,000.00	$30,977	$1,008.47	+$1028095347812062.00M → ORPHY

ORPHY vs DIVO: Complete Analysis 2026

ORPHY — Stock

Orphazyme A/S, a biopharmaceutical company, develops therapies for the treatment of neurodegenerative rare diseases. The company offers heat stock proteins that focuses on the treatment of neurodegenerative diseases by harnessing the cell protective properties of the heat shock response, which protects cells from the accumulation of misfolded proteins, aggregated proteins, and dysfunctional lysosomes. Its lead candidate is the Arimoclomol, which is in clinical development for diseases, including Niemann-Pick disease type C, Amyotrophic Lateral Sclerosis, and Inclusion Body Myositis. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark.

Full ORPHY Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this ORPHY vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ORPHY vs SCHD ORPHY vs JEPI ORPHY vs O ORPHY vs KO ORPHY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.